Literature DB >> 11328903

Procalcitonin for accurate detection of infection in haemodialysis.

S Herget-Rosenthal1, G Marggraf, F Pietruck, J Hüsing, M Strupat, T Philipp, A Kribben.   

Abstract

BACKGROUND: Infection results in considerable morbidity and mortality in haemodialysis patients. Diagnosis of infection can be difficult because currently applied laboratory parameters may be non-specifically altered due to uraemia or haemodialysis (HD). This study investigated the diagnostic value and kinetics of serum procalcitonin (PCT), a low-molecular-weight protein, in patients receiving intermittent HD.
METHODS: Sixty-eight patients receiving intermittent HD for end-stage renal disease (n=48) or acute renal failure (n=20) were prospectively studied, 47 treated with high-flux and 21 with low-flux membranes. Of 36 patients with severe infections or sepsis, 27 were treated with high-flux and nine with low-flux membranes. WBC, serum PCT and C-reactive protein (CRP) concentrations were measured immediately before HD, and PCT repeatedly during the following 48 h.
RESULTS: When determined immediately before HD, PCT demonstrated a sensitivity of 89%, a specificity of 81%, and positive and negative predictive values of 84 and 87%, indicating severe infection or sepsis. These levels were higher than the respective values for CRP (89, 48, 68 and 78%) and WBC (58, 75, 71 and 59%). After 4 h of HD with high-flux membranes, PCT decreased significantly to 83+/-25% and did not return to predialysis concentrations before 48 h. This decrease in serum PCT resulted in markedly reduced sensitivity (65%) and negative predictive value (54%). In contrast, no marked change in PCT concentration occurred during or after HD with low-flux membranes.
CONCLUSION: Serum PCT is an accurate indicator of severe infection and sepsis in patients receiving intermittent HD. High-flux membranes substantially decrease PCT. When utilizing high flux membranes, serum PCT concentrations should be determined prior to the start of HD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328903     DOI: 10.1093/ndt/16.5.975

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

1.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

Review 2.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

3.  Procalcitonin serum levels in children undergoing chronic haemodialysis.

Authors:  Fleur Lorton; Frédérique Veinberg; Dominique Ielsch; Georges Deschênes; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

4.  Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department.

Authors:  R Schneider; M J Cohen; S Benenson; O Duchin; Y S Haviv; M Elhalel-Darnitski; P D Levin
Journal:  Intern Emerg Med       Date:  2019-07-27       Impact factor: 3.397

5.  Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis.

Authors:  Ashraf A Dahaba; Peter H Rehak; Werner F List
Journal:  Intensive Care Med       Date:  2003-03-22       Impact factor: 17.440

6.  Changes of Early Sepsis Biomarker Presepsin Level during Hemodialysis: Influence of β2-Microglobulin Clearance of Dialysis Membrane: A Preliminary Study.

Authors:  Jun Shiota
Journal:  Kidney Dis (Basel)       Date:  2018-10-09

7.  Procalcitonin serum levels in stage 5 chronic kidney disease children on hemodialysis.

Authors:  Antoine Mouche; Cyrielle Parmentier; Claire Herbez Rea; Thérèsa Kwon; Olivia Boyer; Jean Daniel Delbet; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.714

8.  Use of procalcitonin in patients on chronic hemodialysis: procalcitonin is not related with increased serum calcitonin.

Authors:  Ken-Ichi Mori; Mitsuru Noguchi; Yasuhiro Sumino; Fuminori Sato; Hiromitsu Mimata
Journal:  ISRN Urol       Date:  2012-05-20

9.  Cardiorenal biomarkers in acute heart failure.

Authors:  Rajiv Choudhary; Dipika Gopal; Ben A Kipper; Alejandro De La Parra Landa; Hermineh Aramin; Elizabeth Lee; Saloni Shah; Alan S Maisel
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

10.  Measurements in the intensive care unit: what do they mean?

Authors:  John C Marshall
Journal:  Crit Care       Date:  2003-11-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.